227 related articles for article (PubMed ID: 33237535)
21. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
22. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers.
Lim HX; Kim TS; Poh CL
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443699
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
24. Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells.
Barouni RM; Musiu C; Bronte V; Ugel S; Canè S
Methods Mol Biol; 2021; 2236():29-42. PubMed ID: 33237538
[TBL] [Abstract][Full Text] [Related]
25. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
Groth C; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V
Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592
[TBL] [Abstract][Full Text] [Related]
26. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
27. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.
Cassetta L; Baekkevold ES; Brandau S; Bujko A; Cassatella MA; Dorhoi A; Krieg C; Lin A; Loré K; Marini O; Pollard JW; Roussel M; Scapini P; Umansky V; Adema GJ
Cancer Immunol Immunother; 2019 Apr; 68(4):687-697. PubMed ID: 30684003
[TBL] [Abstract][Full Text] [Related]
28. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
30. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
Front Immunol; 2019; 10():691. PubMed ID: 31001284
[TBL] [Abstract][Full Text] [Related]
31. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
32. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
Nelson N; Szekeres K; Cooper D; Ghansah T
J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
[TBL] [Abstract][Full Text] [Related]
33. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM; Dorhoi A; Esendagli G; Barczyk-Kahlert K; van der Bruggen P; Lipoldova M; Perecko T; Santibanez J; Saraiva M; Van Ginderachter JA; Brandau S
Cancer Immunol Immunother; 2019 Apr; 68(4):631-644. PubMed ID: 29785656
[TBL] [Abstract][Full Text] [Related]
34. Myeloid-Derived Suppressor Cells in Lung Transplantation.
Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
Front Immunol; 2019; 10():900. PubMed ID: 31080450
[TBL] [Abstract][Full Text] [Related]
35. Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis.
Kadić E; Moniz RJ; Huo Y; Chi A; Kariv I
BMC Immunol; 2017 Feb; 18(1):6. PubMed ID: 28148223
[TBL] [Abstract][Full Text] [Related]
36. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
Mandruzzato S; Brandau S; Britten CM; Bronte V; Damuzzo V; Gouttefangeas C; Maurer D; Ottensmeier C; van der Burg SH; Welters MJ; Walter S
Cancer Immunol Immunother; 2016 Feb; 65(2):161-9. PubMed ID: 26728481
[TBL] [Abstract][Full Text] [Related]
37. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
[TBL] [Abstract][Full Text] [Related]
38. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis.
Wang Y; Tian J; Wang S
Semin Arthritis Rheum; 2016 Feb; 45(4):490-5. PubMed ID: 26272193
[TBL] [Abstract][Full Text] [Related]
39. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
Zhou J; Nefedova Y; Lei A; Gabrilovich D
Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
[TBL] [Abstract][Full Text] [Related]
40. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer.
Ugolini A; Tyurin VA; Tyurina YY; Tcyganov EN; Donthireddy L; Kagan VE; Gabrilovich DI; Veglia F
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
